SECTION 1
Historical Context & The Evolution of Substance Use Care
The clinical understanding of substance use disorders has undergone a profound transformation over the past two centuries. For much of Western medical history, excessive alcohol or drug use was viewed purely as a moral failing rather than a medical condition, and treatment often consisted of incarceration or institutionalization in asylums. The emergence of the disease model of addiction in the mid-twentieth century fundamentally shifted how clinicians approach assessment, withdrawal management, and overdose response. This paradigm shift is especially relevant for practical nurses, who frequently serve as the first point of contact for clients in acute substance-related crises and must integrate psychosocial support with evidence-based medical interventions.
1935 • Founding of Alcoholics Anonymous
1956 • AMA Declares Alcoholism a Disease
1971 • Methadone Maintenance Approved
2013 • DSM-5 Redefines Substance Use Disorders
2023 • Harm Reduction as Standard Practice
Today, practical nurses must answer a critical clinical question: how do we assess, stabilize, and support a client whose substance use has reached a point of physiological crisis—whether through active intoxication, dangerous withdrawal, or life-threatening overdose? This lesson addresses that question comprehensively, equipping you with the knowledge base required for the NCLEX-PN Psychosocial Integrity domain.
SECTION 2
Core Principles of Substance Use, Withdrawal, and Overdose Care
Effective nursing care for substance-related conditions rests on several foundational principles that guide clinical assessment and intervention. Understanding these principles ensures that the practical nurse can differentiate between intoxication, withdrawal, and overdose presentations—three conditions that demand distinctly different interventions despite arising from the same underlying disorder. These principles also underscore the importance of a non-judgmental, patient-centered approach that treats the client with dignity while prioritizing physiological safety.
Tolerance & Physiological Dependence
Withdrawal as a Medical Emergency
Overdose Recognition & Reversal
Harm Reduction Philosophy
Therapeutic Communication
KEY TAKEAWAY
SECTION 3
Visual Overview: Intoxication, Withdrawal, and Overdose Pathways
The diagram above illustrates the clinical trajectory that a practical nurse must understand. Substance use begins as a voluntary behavior, but repeated exposure leads to neuroadaptive changes that produce tolerance and physiological dependence. Once a substance use disorder is established, three distinct crisis presentations can emerge. Intoxication reflects the acute pharmacological effects of the substance on the central nervous system. Withdrawal occurs when a dependent individual abruptly reduces or stops use, triggering a rebound response opposite to the drug's usual effects. Overdose represents a toxic dose that overwhelms the body's compensatory mechanisms and can rapidly progress to organ failure and death. All three pathways demand the same foundational nursing approach: ensuring airway, breathing, and circulation; performing standardized assessments; administering ordered pharmacological agents; and maintaining a therapeutic, non-judgmental presence.
SECTION 4
Mechanisms of Withdrawal and Overdose
Neurobiological Basis of Withdrawal
When a substance is used chronically, the central nervous system adapts through neuroadaptation—the upregulation or downregulation of neurotransmitter receptors to maintain homeostasis in the presence of the drug. Central nervous system (CNS) depressants such as alcohol and benzodiazepines enhance gamma-aminobutyric acid (GABA) activity, which inhibits neural firing. Over time, the brain compensates by increasing excitatory glutamate receptors and decreasing inhibitory GABA receptors. When the depressant is suddenly removed, the brain is left in a hyperexcitable state, producing withdrawal symptoms such as tremors, seizures, tachycardia, hypertension, and in severe cases, delirium tremens. Conversely, stimulant withdrawal from agents like cocaine or amphetamines produces a 'crash' characterized by fatigue, depression, and hypersomnia—reflecting the depletion of dopamine and norepinephrine after sustained overactivity.
Overdose Pathophysiology by Drug Class
Overdose pathophysiology varies by substance class but consistently involves the overwhelming of normal physiological regulatory mechanisms. Opioid overdose is driven by excessive activation of mu-opioid receptors in the brainstem respiratory center, leading to progressive respiratory depression, hypoxia, and eventually respiratory arrest. The antidote, naloxone (Narcan), acts as a competitive antagonist at these receptors, displacing the opioid and rapidly restoring respiratory drive. Alcohol and benzodiazepine overdoses also cause CNS and respiratory depression, but the mechanism involves GABA-A receptor potentiation. Flumazenil reverses benzodiazepine overdose but is used cautiously because it may precipitate seizures in chronic benzodiazepine users. Stimulant overdose produces a sympathomimetic toxidrome—severe hypertension, hyperthermia, tachyarrhythmias, and potential for stroke or myocardial infarction—requiring supportive cooling, benzodiazepines for agitation, and careful hemodynamic monitoring.
Clinical Alert: Life-Threatening Withdrawals
| Substance Class | Withdrawal Symptoms | Overdose Symptoms | Key Antidote/Intervention |
|---|---|---|---|
| Opioids | Rhinorrhea, lacrimation, piloerection, myalgia, diarrhea, restlessness, yawning | Respiratory depression, miosis (pinpoint pupils), sedation, bradycardia, cyanosis | Naloxone (Narcan) |
| Alcohol | Tremors, diaphoresis, tachycardia, hypertension, nausea, seizures, delirium tremens (48−72 hrs) | Ataxia, slurred speech, respiratory depression, hypothermia, coma | Benzodiazepines (chlordiazepoxide, lorazepam); thiamine IV |
| Benzodiazepines | Anxiety, insomnia, tremors, seizures, psychosis (similar to alcohol withdrawal) | Excessive sedation, respiratory depression, hypotension | Flumazenil (use cautiously) |
| Stimulants (cocaine, amphetamines) | Depression, fatigue, hypersomnia, increased appetite, psychomotor retardation | Hypertension, tachycardia, hyperthermia, agitation, seizures, stroke risk | Supportive: benzodiazepines, cooling, no beta-blockers |
| Cannabis | Irritability, insomnia, decreased appetite, mild anxiety | Anxiety, paranoia, tachycardia (rarely life-threatening) | Supportive care, reassurance |
Comparison of withdrawal and overdose presentations across major substance classes
SECTION 5
Standardized Assessment Tools and Classification
Accurate and timely assessment is the cornerstone of safe withdrawal and overdose management. The practical nurse uses standardized instruments to quantify the severity of withdrawal, guide pharmacological dosing decisions, and document changes in the client's condition over time. Two tools are particularly high-yield for NCLEX-PN: the Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar) and the Clinical Opiate Withdrawal Scale (COWS). These validated scoring systems transform subjective clinical observations into objective numeric scores that drive treatment protocols.
The CIWA-Ar is administered at regular intervals—typically every one to two hours—and the resulting score determines whether symptom-triggered benzodiazepine dosing is warranted. A score of 8 or below generally indicates mild withdrawal that can be managed with supportive care alone, while a score of 20 or above signals severe withdrawal requiring aggressive pharmacological intervention and close monitoring for seizures and delirium tremens. The COWS operates on a similar principle for opioid withdrawal and is essential for determining the appropriate timing to initiate medication-assisted treatment (MAT) with buprenorphine or methadone. Initiating buprenorphine too early—before the COWS score reaches at least 8 to 12—can precipitate withdrawal because buprenorphine is a partial agonist that displaces full agonists from opioid receptors.
Alcohol Withdrawal Timeline
SECTION 6
Worked Example: Managing Alcohol Withdrawal Using CIWA-Ar
The following scenario demonstrates how a practical nurse applies the CIWA-Ar protocol in a clinical setting to guide withdrawal management for a client admitted with a history of chronic alcohol use.
Clinical Scenario: Mr. J, 52-year-old Male — Alcohol Withdrawal
- 1
Step 1 — Gather Clinical Data
Mr. J is admitted to the medical-surgical unit 10 hours after his last alcoholic drink. He reports daily consumption of approximately one liter of vodka for the past 8 years. On admission, his vital signs are: BP 162/98, HR 112, T 99.4°F, RR 22. He appears diaphoretic, his hands exhibit a visible tremor when extended, and he reports feeling 'nervous and shaky.' He is oriented to person and place but unsure of the date.Clinical picture: elevated vitals, tremor, diaphoresis, mild disorientation — consistent with alcohol withdrawal - 2
Step 2 — Administer CIWA-Ar Assessment
The nurse completes the CIWA-Ar scoring: Nausea/Vomiting = 3 (mild nausea, no vomiting); Tremor = 4 (moderate, visible with arms extended); Paroxysmal Sweats = 4 (beads on forehead); Anxiety = 4 (moderately anxious, guarded); Agitation = 3 (fidgeting, restless); Tactile Disturbances = 1 (mild itching/numbness); Auditory Disturbances = 1 (mildly harsh sounds); Visual Disturbances = 0; Headache = 2 (mild); Orientation/Clouding = 2 (uncertain about date).CIWA-Ar Total Score: 24 — Severe Withdrawal - 3
Step 3 — Implement Symptom-Triggered Protocol
Per the provider's standing order, a CIWA-Ar score ≥ 20 triggers administration of lorazepam 2 mg IV. The nurse also ensures seizure precautions are in place: padded side rails up, suction at bedside, oxygen readily available. Thiamine 100 mg IV is administered before any glucose-containing fluids to prevent Wernicke encephalopathy. The nurse documents the CIWA-Ar score and plans to reassess in 1 hour.Interventions: Lorazepam 2 mg IV, seizure precautions, thiamine 100 mg IV, reassess CIWA-Ar in 1 hour - 4
Step 4 — Reassess and Adjust
One hour later, the nurse re-administers the CIWA-Ar. Mr. J's tremor has decreased (score = 2), diaphoresis has improved (score = 2), anxiety is reduced (score = 2), and he can now state the correct date (orientation = 0). The new total CIWA-Ar score is 14 (moderate withdrawal). Per protocol, lorazepam 1 mg IV is administered. The nurse continues hourly monitoring and documents the downward trend, indicating the protocol is effective.CIWA-Ar dropped from 24 → 14; continue monitoring, reduced benzodiazepine dose per protocol - 5
Step 5 — Psychosocial Support and Discharge Planning
As Mr. J stabilizes (CIWA-Ar < 8 for three consecutive assessments), the nurse initiates therapeutic communication about his substance use history, using open-ended questions and motivational interviewing techniques. The nurse provides education about community resources including AA meetings, outpatient counseling, and medication-assisted treatment options (naltrexone, disulfiram, or acamprosate). A social work referral is placed, and the nurse documents the client's expressed readiness for change using the Stages of Change model.Holistic care: medical stabilization + psychosocial intervention + discharge planning = comprehensive SUD nursing care
SECTION 7
Pharmacological Interventions: Strengths and Limitations
Pharmacological management forms a critical component of substance use disorder care. The practical nurse must understand the mechanism, indications, and nursing considerations for key medications used in withdrawal management, overdose reversal, and long-term relapse prevention. However, each agent carries specific strengths and limitations that influence clinical decision-making.
| Medication | Indication | Strengths | Limitations / Nursing Considerations |
|---|---|---|---|
| Naloxone (Narcan) | Opioid overdose reversal | Rapid onset (2−5 min IV); available IM, IN, IV; can be administered by laypersons; no abuse potential | Short half-life (30−90 min) — may wear off before opioid, requiring repeat doses; may precipitate acute withdrawal with severe agitation |
| Lorazepam (Ativan) | Alcohol/benzo withdrawal; stimulant OD agitation | No active metabolites (safer in liver disease); versatile route administration (PO, IM, IV) | Risk of respiratory depression, especially with concurrent opioid use; requires careful dose titration using CIWA-Ar |
| Methadone | Opioid use disorder maintenance | Full agonist; long half-life provides 24-hr coverage; reduces cravings and illicit use | Dispensed only through certified opioid treatment programs; risk of QT prolongation; respiratory depression risk |
| Buprenorphine (Suboxone) | Opioid use disorder maintenance/detox | Partial agonist with ceiling effect (lower OD risk); can be prescribed in office settings; combined with naloxone to deter IV misuse | Must wait until sufficient withdrawal (COWS ≥ 8−12) before initiating or precipitated withdrawal occurs; sublingual administration |
| Disulfiram (Antabuse) | Alcohol relapse prevention | Creates aversive reaction with alcohol (flushing, nausea, vomiting); psychological deterrent | Requires strict adherence and motivation; can cause severe reaction if alcohol is consumed; hepatotoxicity risk |
Key pharmacological agents in substance use disorder care
KEY TAKEAWAY
SECTION 8
Connection to Advanced Practice: Co-Occurring Disorders and Trauma-Informed Care
The foundational principles of substance use, withdrawal, and overdose management explored in this lesson directly connect to more advanced clinical frameworks that the practical nurse will encounter in specialized settings. Two concepts are particularly important: the management of co-occurring disorders (also called dual diagnosis) and the application of trauma-informed care principles. Research consistently demonstrates that approximately 50% of individuals with a substance use disorder also meet criteria for at least one concurrent mental health diagnosis, most commonly major depressive disorder, generalized anxiety disorder, post-traumatic stress disorder, or bipolar disorder. The intersection of these conditions complicates both assessment and treatment, as psychiatric symptoms can mimic or mask withdrawal presentations, and withdrawal itself can trigger or exacerbate underlying psychiatric conditions.
| Concept | PN-Level Application | Advanced/RN-Level Application |
|---|---|---|
| Assessment | Administer CIWA-Ar/COWS; report changes in mental status; document objectively | Conduct comprehensive psychiatric evaluations; differentiate substance-induced vs. independent psychiatric disorders |
| Pharmacology | Administer ordered medications; monitor for side effects; educate on MAT basics | Manage complex polypharmacy; titrate psychotropic + MAT regimens; prescriptive authority (NP) |
| Therapeutic Communication | Use motivational interviewing basics; provide non-judgmental support; identify stage of change | Lead group therapy; implement CBT/DBT interventions; conduct family systems therapy |
| Trauma-Informed Care | Ask 'What happened to you?' instead of 'What's wrong with you?'; avoid re-traumatizing procedures; ensure physical and emotional safety | Design program-level trauma-informed policies; implement EMDR and trauma-focused CBT; lead organizational culture change |
PN-Level vs. Advanced Practice approaches to substance use care
As you progress in your nursing career, the assessment and intervention skills you develop at the PN level will serve as the clinical foundation upon which advanced practice competencies are built. The practical nurse's role in early detection, accurate documentation, and compassionate first-contact care is often the critical link between a client entering the healthcare system in crisis and their eventual engagement with long-term recovery services. Familiarity with the Stages of Change model—precontemplation, contemplation, preparation, action, and maintenance—helps the PN meet clients where they are rather than imposing premature expectations of abstinence.
SECTION 9
Practice Problems
Question 1: CONCEPTUAL
Show answer
Question 2: BASIC CALCULATION
Show answer
Question 3: INTERMEDIATE
Show answer
Question 4: APPLIED
Show answer
Question 5: CRITICAL THINKING
Show answer
SUMMARY
Lesson Summary
Summary
Substance use disorders represent a spectrum of conditions rooted in neuroadaptation and physiological dependence that can produce three distinct clinical crises: intoxication, withdrawal, and overdose. The practical nurse uses standardized assessment tools—the CIWA-Ar for alcohol and the COWS for opioids—to quantify withdrawal severity and guide symptom-triggered pharmacological interventions. Critical antidotes include naloxone for opioid overdose and benzodiazepines for alcohol and sedative-hypnotic withdrawal. Remember that withdrawal from alcohol, benzodiazepines, and barbiturates can be life-threatening, while opioid withdrawal, though profoundly distressing, is rarely fatal in otherwise healthy individuals.
Beyond physiological management, effective nursing care demands a non-judgmental, patient-centered approach grounded in therapeutic communication and harm reduction philosophy. The Stages of Change model (precontemplation, contemplation, preparation, action, maintenance) guides the nurse in meeting clients at their current level of readiness. Medication-assisted treatment with methadone, buprenorphine, or naltrexone represents the evidence-based standard for opioid use disorder management, while disulfiram, naltrexone, and acamprosate support alcohol use disorder recovery. The practical nurse's role integrates all of these elements—acute stabilization, accurate assessment, pharmacological support, and compassionate psychosocial care—to promote both immediate safety and long-term recovery.